Epilepsy develops in about 1% of people. The decision to start antiepileptic drug treatment is a diffucult one. It must be based on the risk-benefit ratio; subsequently, questions must be addressed regarding with which drug to use, and for how long. Finally, criteria for terminating treatment must be explained to the patient from the onset of treatment
Starting and stopping treatment.
SPECCHIO, LUIGI MARIA
2008-01-01
Abstract
Epilepsy develops in about 1% of people. The decision to start antiepileptic drug treatment is a diffucult one. It must be based on the risk-benefit ratio; subsequently, questions must be addressed regarding with which drug to use, and for how long. Finally, criteria for terminating treatment must be explained to the patient from the onset of treatmentFile in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
